American Heart Journal
Volume 156, Issue 1 , Pages 4-6 , July 2008

Evaluating diagnostic tests—should the same methods apply?

  • Jenny A. Doust, MD, PhD

      Affiliations

    • Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia
    • Corresponding Author InformationReprint requests: Jenny A. Doust, MD, PhD, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia, QLD 4229.
    • ,
  • Jonathon C. Craig, MD, PhD

      Affiliations

    • School of Public Health, University of Sydney, Sydney, Australia

Received 10 March 2008 ,Accepted 11 March 2008.

References 

  1. Rutten J, Steyerberg EW, Boomsma F, et al. N-terminal pro-brain natriuretic peptide testing in the emergency department: benefecial effects on hospitalization, costs, and outcome. Am Heart J. 2008;156:71–77
  2. Moe GW, Howlett J, Januzzi JL, et al. N-terminal pro–B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007;115:3103–3110
  3. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647–654
  4. Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?. Ann Intern Med. 2006;144:850–855

PII: S0002-8703(08)00220-2

doi: 10.1016/j.ahj.2008.03.014

American Heart Journal
Volume 156, Issue 1 , Pages 4-6 , July 2008

Article Tools

* Image Usage & Resolution